Primary aldosteronism: diagnosis and treatment.
Recent studies have indicated a higher prevalence of primary aldosteronism (PA) than reported historically. Aldosterone excess induces sodium and fluid retention with consequential increases in blood pressure. Patients with PA are at an increased risk of developing left ventricular hypertrophy, chronic kidney disease, and endothelial dysfunction. Measurement of the plasma aldosterone/plasma renin activity ratio is an effective screening test for PA. The majority of patients with PA do not have a discernable aldosterone-producing adenoma (APA), and the aldosterone excess is considered idiopathic in etiology and/or attributed to adrenal hyperplasia. Treatment of PA includes medical therapy with mineralocorticoid receptor antagonists and adrenalectomy for patients with a unilateral APA. A reasonable treatment strategy is to attempt medical therapy in all patients with a high plasma aldosterone/PRA ratio and reserve the extensive workup needed to identify an APA for those patients whose hypertension or hypokalemia cannot be controlled medically.
Pimenta
Eduardo
E
Vascular Biology and Hypertension Program, University of Alabama at Birmingham, 933 19th Street South, Birmingham, AL 35294, USA. eduardo.pimenta@ccc.uab.edu
Calhoun
David A
DA
D003663:Decision Trees; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis* / Q000628:therapy*